Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESGO 2021 | Importance of pathology in gynecological cancer

Xavier Matias-Guiu • 25 Oct 2021
ESGO 2021
Cervical Cancer Endometrial Cancer Gynecological Cancer Ovarian Cancer

Xavier Matias-Guiu, PhD, Biomedical Research Institute of Lleida, Lleida, Spain, explains the importance of pathology in the management of endometrial, cervical, and ovarian cancer. This interview took place at the European Society of Gynaecological Oncology (ESGO) 2021 congress in Prague.

More from Xavier Matias-Guiu

0:58
Highlights for pathology at ESGO
Xavier Matias-Guiu • 25 Oct 2021
0:54
Pathologic risk stratification of gynecological cancer
Xavier Matias-Guiu • 25 Oct 2021

Related Videos

0:39
Early diagnosis of ovarian cancer with Pap smears
Sergio Marchini • 8 Apr 2024
0:46
FRa expression and sequencing ADCs in endometrial cancer
Rebecca Porter • 8 Apr 2024
4:12
PETRA: saruparib in solid tumors with BRCA1/2, PALB2 or RAD51C/D mutations
Timothy Yap • 7 Apr 2024
1:11
Clonal hematopoiesis mutations in ovarian carcinomas
Rebecca Porter • 8 Apr 2024
The content of VJOncology is intended for healthcare professionals